![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: EXOC7 |
Gene summary for EXOC7 |
![]() |
Gene information | Species | Human | Gene symbol | EXOC7 | Gene ID | 23265 |
Gene name | exocyst complex component 7 | |
Gene Alias | 2-5-3p | |
Cytomap | 17q25.1 | |
Gene Type | protein-coding | GO ID | GO:0006810 | UniProtAcc | Q63HP7 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
23265 | EXOC7 | P47T-E | Human | Esophagus | ESCC | 2.84e-16 | 2.68e-01 | 0.1067 |
23265 | EXOC7 | P48T-E | Human | Esophagus | ESCC | 2.80e-25 | 4.79e-01 | 0.0959 |
23265 | EXOC7 | P49T-E | Human | Esophagus | ESCC | 5.35e-14 | 1.09e+00 | 0.1768 |
23265 | EXOC7 | P52T-E | Human | Esophagus | ESCC | 2.37e-19 | 3.82e-01 | 0.1555 |
23265 | EXOC7 | P54T-E | Human | Esophagus | ESCC | 1.96e-11 | 2.76e-01 | 0.0975 |
23265 | EXOC7 | P56T-E | Human | Esophagus | ESCC | 3.80e-12 | 1.31e+00 | 0.1613 |
23265 | EXOC7 | P57T-E | Human | Esophagus | ESCC | 5.87e-14 | 4.26e-01 | 0.0926 |
23265 | EXOC7 | P61T-E | Human | Esophagus | ESCC | 4.11e-29 | 7.45e-01 | 0.099 |
23265 | EXOC7 | P62T-E | Human | Esophagus | ESCC | 1.24e-46 | 7.77e-01 | 0.1302 |
23265 | EXOC7 | P65T-E | Human | Esophagus | ESCC | 3.19e-29 | 5.13e-01 | 0.0978 |
23265 | EXOC7 | P74T-E | Human | Esophagus | ESCC | 6.19e-18 | 5.33e-01 | 0.1479 |
23265 | EXOC7 | P75T-E | Human | Esophagus | ESCC | 8.27e-35 | 7.49e-01 | 0.1125 |
23265 | EXOC7 | P76T-E | Human | Esophagus | ESCC | 6.79e-23 | 3.09e-01 | 0.1207 |
23265 | EXOC7 | P79T-E | Human | Esophagus | ESCC | 2.48e-28 | 5.00e-01 | 0.1154 |
23265 | EXOC7 | P80T-E | Human | Esophagus | ESCC | 1.10e-38 | 1.09e+00 | 0.155 |
23265 | EXOC7 | P82T-E | Human | Esophagus | ESCC | 8.80e-12 | 4.89e-01 | 0.1072 |
23265 | EXOC7 | P83T-E | Human | Esophagus | ESCC | 1.31e-23 | 5.68e-01 | 0.1738 |
23265 | EXOC7 | P84T-E | Human | Esophagus | ESCC | 2.61e-11 | 4.73e-01 | 0.0933 |
23265 | EXOC7 | P89T-E | Human | Esophagus | ESCC | 4.92e-18 | 9.69e-01 | 0.1752 |
23265 | EXOC7 | P91T-E | Human | Esophagus | ESCC | 2.75e-13 | 1.18e+00 | 0.1828 |
Page: 1 2 3 4 5 6 7 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:001050616 | Esophagus | HGIN | regulation of autophagy | 84/2587 | 317/18723 | 1.39e-09 | 1.08e-07 | 84 |
GO:001623616 | Esophagus | HGIN | macroautophagy | 77/2587 | 291/18723 | 7.15e-09 | 4.61e-07 | 77 |
GO:004440326 | Esophagus | HGIN | biological process involved in symbiotic interaction | 71/2587 | 290/18723 | 7.09e-07 | 3.00e-05 | 71 |
GO:005170127 | Esophagus | HGIN | biological process involved in interaction with host | 51/2587 | 203/18723 | 1.16e-05 | 3.29e-04 | 51 |
GO:00162418 | Esophagus | HGIN | regulation of macroautophagy | 38/2587 | 141/18723 | 2.80e-05 | 7.21e-04 | 38 |
GO:005212627 | Esophagus | HGIN | movement in host environment | 43/2587 | 175/18723 | 9.45e-05 | 2.03e-03 | 43 |
GO:004390320 | Esophagus | HGIN | regulation of biological process involved in symbiotic interaction | 20/2587 | 72/18723 | 1.39e-03 | 1.63e-02 | 20 |
GO:004440927 | Esophagus | HGIN | entry into host | 34/2587 | 151/18723 | 2.43e-03 | 2.43e-02 | 34 |
GO:001623617 | Esophagus | ESCC | macroautophagy | 216/8552 | 291/18723 | 1.94e-23 | 4.57e-21 | 216 |
GO:001050617 | Esophagus | ESCC | regulation of autophagy | 220/8552 | 317/18723 | 6.72e-18 | 6.36e-16 | 220 |
GO:001624114 | Esophagus | ESCC | regulation of macroautophagy | 102/8552 | 141/18723 | 1.09e-10 | 3.27e-09 | 102 |
GO:0044403111 | Esophagus | ESCC | biological process involved in symbiotic interaction | 186/8552 | 290/18723 | 1.43e-10 | 4.16e-09 | 186 |
GO:0051701111 | Esophagus | ESCC | biological process involved in interaction with host | 135/8552 | 203/18723 | 1.49e-09 | 3.49e-08 | 135 |
GO:0052126111 | Esophagus | ESCC | movement in host environment | 117/8552 | 175/18723 | 1.14e-08 | 2.26e-07 | 117 |
GO:0044409111 | Esophagus | ESCC | entry into host | 96/8552 | 151/18723 | 6.73e-06 | 6.84e-05 | 96 |
GO:0043903111 | Esophagus | ESCC | regulation of biological process involved in symbiotic interaction | 49/8552 | 72/18723 | 1.03e-04 | 7.26e-04 | 49 |
GO:005237219 | Esophagus | ESCC | modulation by symbiont of entry into host | 32/8552 | 49/18723 | 4.39e-03 | 1.73e-02 | 32 |
GO:004440312 | Liver | Cirrhotic | biological process involved in symbiotic interaction | 131/4634 | 290/18723 | 2.00e-14 | 1.84e-12 | 131 |
GO:001623611 | Liver | Cirrhotic | macroautophagy | 129/4634 | 291/18723 | 1.75e-13 | 1.41e-11 | 129 |
GO:001050611 | Liver | Cirrhotic | regulation of autophagy | 132/4634 | 317/18723 | 2.17e-11 | 1.33e-09 | 132 |
Page: 1 2 3 4 5 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
hsa0513239 | Esophagus | HGIN | Salmonella infection | 69/1383 | 249/8465 | 3.02e-06 | 4.47e-05 | 3.55e-05 | 69 |
hsa05132115 | Esophagus | HGIN | Salmonella infection | 69/1383 | 249/8465 | 3.02e-06 | 4.47e-05 | 3.55e-05 | 69 |
hsa05132211 | Esophagus | ESCC | Salmonella infection | 191/4205 | 249/8465 | 6.51e-19 | 5.45e-17 | 2.79e-17 | 191 |
hsa049109 | Esophagus | ESCC | Insulin signaling pathway | 89/4205 | 137/8465 | 1.97e-04 | 7.32e-04 | 3.75e-04 | 89 |
hsa05132310 | Esophagus | ESCC | Salmonella infection | 191/4205 | 249/8465 | 6.51e-19 | 5.45e-17 | 2.79e-17 | 191 |
hsa0491014 | Esophagus | ESCC | Insulin signaling pathway | 89/4205 | 137/8465 | 1.97e-04 | 7.32e-04 | 3.75e-04 | 89 |
hsa0513222 | Liver | Cirrhotic | Salmonella infection | 121/2530 | 249/8465 | 2.47e-10 | 5.13e-09 | 3.16e-09 | 121 |
hsa0491021 | Liver | Cirrhotic | Insulin signaling pathway | 56/2530 | 137/8465 | 3.74e-03 | 1.50e-02 | 9.26e-03 | 56 |
hsa0513232 | Liver | Cirrhotic | Salmonella infection | 121/2530 | 249/8465 | 2.47e-10 | 5.13e-09 | 3.16e-09 | 121 |
hsa0491031 | Liver | Cirrhotic | Insulin signaling pathway | 56/2530 | 137/8465 | 3.74e-03 | 1.50e-02 | 9.26e-03 | 56 |
hsa0513242 | Liver | HCC | Salmonella infection | 178/4020 | 249/8465 | 5.90e-15 | 1.98e-13 | 1.10e-13 | 178 |
hsa0491041 | Liver | HCC | Insulin signaling pathway | 95/4020 | 137/8465 | 1.53e-07 | 1.97e-06 | 1.10e-06 | 95 |
hsa0513252 | Liver | HCC | Salmonella infection | 178/4020 | 249/8465 | 5.90e-15 | 1.98e-13 | 1.10e-13 | 178 |
hsa0491051 | Liver | HCC | Insulin signaling pathway | 95/4020 | 137/8465 | 1.53e-07 | 1.97e-06 | 1.10e-06 | 95 |
hsa0513230 | Oral cavity | OSCC | Salmonella infection | 174/3704 | 249/8465 | 2.67e-17 | 1.49e-15 | 7.58e-16 | 174 |
hsa049108 | Oral cavity | OSCC | Insulin signaling pathway | 83/3704 | 137/8465 | 4.83e-05 | 2.00e-04 | 1.02e-04 | 83 |
hsa05132114 | Oral cavity | OSCC | Salmonella infection | 174/3704 | 249/8465 | 2.67e-17 | 1.49e-15 | 7.58e-16 | 174 |
hsa0491013 | Oral cavity | OSCC | Insulin signaling pathway | 83/3704 | 137/8465 | 4.83e-05 | 2.00e-04 | 1.02e-04 | 83 |
hsa05132210 | Oral cavity | LP | Salmonella infection | 128/2418 | 249/8465 | 1.17e-14 | 2.79e-13 | 1.80e-13 | 128 |
hsa0513238 | Oral cavity | LP | Salmonella infection | 128/2418 | 249/8465 | 1.17e-14 | 2.79e-13 | 1.80e-13 | 128 |
Page: 1 2 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
EXOC7 | SNV | Missense_Mutation | c.2064N>C | p.Gln688His | p.Q688H | Q9UPT5 | protein_coding | tolerated(0.07) | probably_damaging(0.979) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
EXOC7 | SNV | Missense_Mutation | c.1728N>A | p.Phe576Leu | p.F576L | Q9UPT5 | protein_coding | deleterious(0) | probably_damaging(0.993) | TCGA-AC-A23H-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | PD | |
EXOC7 | SNV | Missense_Mutation | c.1252N>T | p.Arg418Trp | p.R418W | Q9UPT5 | protein_coding | deleterious(0) | probably_damaging(0.978) | TCGA-B6-A0WT-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | PD | |
EXOC7 | SNV | Missense_Mutation | c.1374N>C | p.Lys458Asn | p.K458N | Q9UPT5 | protein_coding | deleterious(0.01) | possibly_damaging(0.805) | TCGA-C8-A12P-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Unknown | Unknown | SD | |
EXOC7 | SNV | Missense_Mutation | novel | c.553N>A | p.Asp185Asn | p.D185N | Q9UPT5 | protein_coding | tolerated(0.25) | benign(0.024) | TCGA-D8-A147-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicine | SD |
EXOC7 | SNV | Missense_Mutation | c.1456G>A | p.Asp486Asn | p.D486N | Q9UPT5 | protein_coding | tolerated(0.05) | benign(0.088) | TCGA-D8-A27G-01 | Breast | breast invasive carcinoma | Female | >=65 | I/II | Unknown | Unknown | SD | |
EXOC7 | SNV | Missense_Mutation | novel | c.1196N>C | p.Ile399Thr | p.I399T | Q9UPT5 | protein_coding | deleterious(0) | probably_damaging(0.922) | TCGA-E9-A1NC-01 | Breast | breast invasive carcinoma | Female | <65 | I/II | Chemotherapy | doxorubicin | CR |
EXOC7 | SNV | Missense_Mutation | c.2116N>A | p.Val706Met | p.V706M | Q9UPT5 | protein_coding | tolerated(0.12) | benign(0.225) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR | |
EXOC7 | SNV | Missense_Mutation | novel | c.1627N>T | p.Arg543Trp | p.R543W | Q9UPT5 | protein_coding | deleterious(0.01) | probably_damaging(0.931) | TCGA-2W-A8YY-01 | Cervix | cervical & endocervical cancer | Female | <65 | I/II | Chemotherapy | cisplatin | CR |
EXOC7 | SNV | Missense_Mutation | c.988N>T | p.His330Tyr | p.H330Y | Q9UPT5 | protein_coding | tolerated(0.65) | benign(0) | TCGA-EK-A2PG-01 | Cervix | cervical & endocervical cancer | Female | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 2 3 4 5 6 7 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |